About Universitetssykehuset i Nord-Norge, Harstad
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
1
Helse Møre og Romsdal HF
1
Clinical Trials at Universitetssykehuset i Nord-Norge, Harstad
During the past decade, Universitetssykehuset i Nord-Norge, Harstad conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
2017-06-09
2025-02-01
Active, not recruiting
174
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitetssykehuset i Nord-Norge, Harstad"
#1 collaborator was "Oslo University Hospital" with 1 trials as a collaborator and "University of Oslo" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universitetssykehuset i Nord-Norge, Harstad
According to Clinical.Site data, the most researched conditions in "Universitetssykehuset i Nord-Norge, Harstad" are
"Atrial Fibrillation" (1 trials), "Colitis,Ulcerative" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Universitetssykehuset i Nord-Norge, Harstad" in a lesser frequency.
Clinical Trials Intervention Types at Universitetssykehuset i Nord-Norge, Harstad
Most popular intervention types in "Universitetssykehuset i Nord-Norge, Harstad" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Continuation of anti-TNF treatment" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitetssykehuset i Nord-Norge, Harstad
The vast majority of trials in "Universitetssykehuset i Nord-Norge, Harstad" are
2 trials for "All" genders.
Clinical Trials Status at Universitetssykehuset i Nord-Norge, Harstad
Currently, there are NaN active trials in "Universitetssykehuset i Nord-Norge, Harstad".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Universitetssykehuset i Nord-Norge, Harstad,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitetssykehuset i Nord-Norge, Harstad, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".